Technology
Mar. 6, 2024
At the intersection of technology and biology
The legal challenges and opportunities of applying AI and machine learning to different industries, especially biotech, and how the convergence of legacy technologies creates new issues.
Jason Novak
Partner
Norton Rose Fulbright US LLP
As we emerge from the pandemic, Machine Learning (ML) and Artificial Intelligence (AI) have become part of the vernacular, part of everyday discussion, a source of hope, and a source of concern. In the realm of public discourse, AI/ML is often discussed from the perspective of internet searching, social media applications, and the like. In the legal industry, it is often discussed as a tool for legal efficiency. But there is another source of conversation, one that d...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In